Tharimmune Operating Income

Tharimmune (THAR) currently reports a operating income of $-54M as of March 2026. That compares with $-13M in the prior-year period — down 330.8% year over year. Use the charts on this page to explore Tharimmune's operating income history and peer comparisons.

Tharimmune's operating income decreased from $-13M to $-54M — a 330.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tharimmune reported $-54M in operating income as of March 2026. That compares with $-13M in the prior-year period — down 330.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-54M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tharimmune, and consider following THAR for alerts when major investors trade the stock.

Tharimmune is classified in the Healthcare sector. On operating income, it currently shows $-54M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing THAR with unrelated industries.